In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
about
In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central EthiopiaCharacterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingIn vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.Molecular epidemiology of Plasmodium vivax anti-folate resistance in India.Plasmodium vivax treatments: what are we looking for?Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.A lactate dehydrogenase ELISA-based assay for the in vitro determination of Plasmodium berghei sensitivity to anti-malarial drugs.Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivityDihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.Effects of supportive-expressive group therapy in breast cancer patients with affective disorders: a pilot study.Diagnosis and Treatment of Plasmodium vivax Malaria.
P2860
Q28533253-80BAFE7E-6DCE-4CDD-8B8B-6123E172AE72Q28554466-93C5EA12-1B15-4E62-90A4-85C1C247E7E6Q33704762-ACFD8FA7-7606-45DC-85FB-2A745E69E67AQ33715256-791B4D67-0F52-4C31-ADE2-85D6C0F8BDAFQ34995136-25FA6689-637F-4A0B-B080-EE115022BF74Q35760893-3EC8CAAF-1B2E-44E6-AA99-8202DC95F3A2Q36232661-3BA65787-7DB8-4460-BF97-25F8837A0681Q36513344-A96EE6E6-0A49-45DF-B599-67D7C3F9C406Q37263905-A05270C4-20CB-4708-A927-8CB196F48A0CQ37490566-DB70BF9F-F5D9-4C4E-B43A-6D3C665A8B5FQ41934084-F1017B33-E236-45B5-A094-C7D0B7590DDBQ47334799-1465CF58-6124-4DC2-BEE4-8C6F81CFAD34Q53767337-9DEF3FE2-D59B-45AC-A0C1-F3DB7BE7ED86
P2860
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
In vivo and in vitro efficacy ...... ne-resistant Plasmodium vivax.
@ast
In vivo and in vitro efficacy ...... ne-resistant Plasmodium vivax.
@en
type
label
In vivo and in vitro efficacy ...... ne-resistant Plasmodium vivax.
@ast
In vivo and in vitro efficacy ...... ne-resistant Plasmodium vivax.
@en
prefLabel
In vivo and in vitro efficacy ...... ne-resistant Plasmodium vivax.
@ast
In vivo and in vitro efficacy ...... ne-resistant Plasmodium vivax.
@en
P2093
P2860
P50
P921
P356
P1476
In vivo and in vitro efficacy ...... ine-resistant Plasmodium vivax
@en
P2093
A R Hasugian
A Ratcliff
E Kenangalem
F Chalfien
H L E Purba
H Siswantoro
N M Anstey
P2860
P304
P356
10.1128/AAC.01511-08
P407
P577
2008-12-22T00:00:00Z